Evidence map›Paper›PMID 38004552›Full record

ArticlePharmaceutics2023

Lipid Nanoparticles Loading Steroidal Alkaloids of Tomatoes Affect Neuroblastoma Cell Viability in an In Vitro Model.

Debora Santonocito, Agatina Campisi, Rosalia Pellitteri, Giovanni Sposito, Manuela Giovanna Basilicata, Giovanna Aquino, Giacomo Pepe, Maria Grazia Sarpietro, Maria Gaetana Giovanna Pittalà, Aurelie Schoubben and 2 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Debora SantonocitoDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0001-5322-5172
Agatina CampisiDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0002-9808-4681
Rosalia PellitteriInstitute for Biomedical Research and Innovation (IRIB), National Research Council, Via P. Gaifami 18, 95126 Catania, Italy.ORCID 0000-0002-1551-5467
Giovanni SpositoDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
Manuela Giovanna BasilicataDepartment of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, SA, Italy.
Giovanna AquinoDepartment of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, SA, Italy.ORCID 0000-0001-5457-1712
Giacomo PepeDepartment of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, SA, Italy.
Maria Grazia SarpietroDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0002-6799-4754
Maria Gaetana Giovanna PittalàLaboratory of Organic Mass Spectrometry, Department of Chemical Sciences, Viale Andrea Doria 6, 95125 Catania, Italy.
Aurelie SchoubbenDepartment of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0002-2567-519X
Rosario PignatelloDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0002-5937-4192
Carmelo PugliaDepartment of Drug and Health Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0002-7694-3641

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tomato by-products represent a good source of phytochemical compounds with health properties, such as the steroidal glycoalkaloid α-tomatine (α-TM) and its aglycone tomatidine (TD). Both molecules have numerous beneficial properties, such as potential anticancer activity. Unfortunately, their therapeutic application is limited due to stability and bioavailability issues. Therefore, a valid strategy seems to be their encapsulation into Solid Lipid Nanoparticles (SLN). The nanoformulations containing α-TM (α-TM-SLN) and TD (TD-SLN) were prepared by

Indexed as

cellular viabilitylipid nanoparticlestomatidinetomatine

Identifiers

PMID38004552
PMCPMC10675799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.